Erratum: Low plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients (International Urology and Nephrology DOI: 10.1007/s11255-011-0064-1);Low plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients

International Urology and Nephrology

Volumn 44, Issue 4, 2012, Pages 1151-1157

  Kacso, I ^a   Lenghel, A ^a   Bondor, C I ^a   Moldovan, D ^a   Rusu, C ^a   Nita, C ^a   Kacso, G ^a   Hancu, N ^a   Gherman Caprioara, M ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Adiponectin; Albuminuria; Chronic kidney disease; Progression; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ALBUMIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEINURIA; URINALYSIS; WAIST CIRCUMFERENCE;

EID: 84867892531     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0179-z     Document Type: Erratum

References (31)

1. Jansson PA, Pellmé F, Hammarstedt A et al (2003) A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J 17:1434-1440
2. Hopkins TA, Ouchi N, Shibata R, Walsh K (2007) Adiponectin actions in the cardiovascular system. Cardiovasc Res 74(1):11-18
3. Szmitko PE, Teoh H, Stewart DJ, Verma S (2007) Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol 292(4):1655-1663
4. Kadowaki T (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes and the metabolic syndrome. J Clin Invest 116:1784-1792
5. Nawrocki AR, Rajala MW, Tomas E et al (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator- activated receptor c agonists. J Biol Chem 281(5): 2654-2660
6. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302(2):179-188
7. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D (2005) Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol DialTransplant 20(1):129-134
8. Schalkwijk CG, Chaturvedi N, Schram MT, Fuller JH, Stehouwer CD (2006) Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 91(1):129-135
9. Komaba H, Igaki N, Goto S et al (2006) Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 26(5):476-482
10. Norata GD, Baragetti I, Raselli S et al (2010) Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis 20(1):56-63
11. Barlovic DP, Zaletel J, Prezelj J (2009) Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes. Cytokine 46(1):142-145
12. Saraheimo M, Forsblom C, Thorn L et al (2005) Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 28(6):1410-1414
13. Bakkaloglu SA, Soylemezoglu O, Buyan N et al (2005) High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse. Pediatr Nephrol 20(4): 474-477
14. Shimotomai T, Kakei M, Narita T et al (2005) Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria. Ren Fail 27(3):323-328
15. Oguz Y, Yilmaz MI, Acikel C et al (2009) The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and nonnephrotic proteinuria. Ren Fail 31(1):29-35
16. Ohashi K, Iwatani H, Kihara S et al (2007) Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 27(9):1910-1917
17. Sharma K, Ramachandrarao S, Qiu G et al (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118(5):1645-1656
18. Matsuzawa Y (2010) Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci 86(2):131-141
19. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
20. Zoccali C, Mallamaci F, Tripepi G et al (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134-141
21. Ramos LF, Shintani A, Himmelfarb J, Ikizler TA (2009) Determinants of plasma adiponectin levels in nondiabetic subjects with moderate to severe chronic kidney disease. J Ren Nutr 19(3):197-203
22. Hotta K, Funahashi T, Arita Y et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20(6):1595-1599
23. Looker HC, Krakoff J, Funahashi T et al (2004) Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89(8):4010-4017
24. Gottsäter A, Szelag B, Kangro M, Wroblewski M, Sundkvist G (2004) Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes. Eur J Endocrinol 151(3):361-366
25. Lin J, Hu FB, Curhan G (2007) Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care 30(2):239-244
26. Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F (2007) Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the mild to moderate kidney disease study. Kidney Int 71(12):1279-1286
27. Jorsal A, Tarnow L, Frystyk J et al (2008) Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 74(5):649-654
28. Menon V, Li L, Wang X et al (2006) Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17(9):2599-2606
29. Zoccali C, Mallamaci F (2007) Adiponectin and renal disease progression: another epidemiologic conundrum? Kidney Int 71(12):1195-1197
30. Zoccali C, Mallamaci F (2011) Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers? J Ren Nutr 21(1):87-91
31. Stenvinkel P (2011) Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation. J Ren Nutr 21(1):82-86